Evidence map›Paper›PMID 38058399›Full record

ArticleWorld journal of cardiology2023

Novel predictors of permanent pacemaker implantation following transcatheter aortic valve replacement.

Somto Nwaedozie, Haibin Zhang, Javad Najjar Mojarrab, Param Sharma, Paul Yeung, Peter Umukoro, Deepa Soodi, Rachel Gabor, Kelley Anderson, Romel Garcia-Montilla

Open access · diamondAbstract read
In one paragraph

Article in World journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Somto NwaedozieDepartment of Cardiovascular Disease, Marshfield Clinic, Marshfield, WI 54449, United States. nwaedozie.somto@marshfieldclinic.org.
Haibin ZhangHospitalist Medicine, Marshfield Clinic, Marshfield, WI 54449, United States.
Javad Najjar MojarrabDepartment of Nephrology, Henry Ford Health System, Detroit, MI 48202, United States.
Param SharmaDepartment of Cardiovascular Disease, Marshfield Clinic, Marshfield, WI 54449, United States.
Paul YeungDepartment of Hospital Medicine, Marshfield Clinic, Marshfield, WI 54449, United States.
Peter UmukoroDepartment of Nephrology, Hendricks Regional Health, Danville, IN 46122, United States.
Deepa SoodiDepartment of Cardiovascular Disease, Marshfield Clinic, Marshfield, WI 54449, United States.
Rachel GaborClinical Research Center, Marshfield Clinic, Marshfield, WI 54449, United States.
Kelley AndersonDepartment of Cardiovascular Disease, Marshfield Clinic, Marshfield, WI 54449, United States.
Romel Garcia-MontillaDepartment of Trauma Surgery and Surgical Critical Care, Marshfield Clinic, Marshfield, WI 54449, United States.
Marshfield Clinic · USHenry Ford Health System · USRegional Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConduction and rhythm abnormalities requiring permanent pacemakers (PPM) are short-term complications following transcatheter aortic valve replacement (TAVR), and their clinical outcomes remain conflicting. Potential novel predictors of post-TAVR PPM, like QRS duration, QTc prolongation, and supraventricular arrhythmias, have been poorly studied.

aimTo evaluate the effects of baseline nonspecific interventricular conduction delay and supraventricular arrhythmia on post-TAVR PPM requirement and determine the impact of PPM implantation on clinical outcomes.

methodsA retrospective cohort study that identified patients with TAVR between January 1, 2012 to December 31, 2019. The group was dichotomized into those with post-TAVR PPM and those without PPM. Both groups were followed for one year.

resultsOut of the 357 patients that met inclusion criteria, the mean age was 80 years, 188 (52.7%) were male, and 57 (16%) had a PPM implantation. Baseline demographics, valve type, and cardiovascular risk factors were similar except for type II diabetes mellitus (DM), which was more prevalent in the PPM cohort (59.6%

conclusionPre-TAVR type II DM and QRS duration > 120, regardless of the presence of bundle branch blocks, are predictors of post-TAVR PPM. At 1-year post-TAVR, patients with PPM have higher odds of HF hospitalization and MI.

Indexed as

Balloon-expandable valveCoronary artery bypass graftCoronary artery diseaseLeft bundle-branch blockMyocardial infarctionNonspecific inter-ventricular defectSelf-expandable valveTranscatheter aortic valve replacement

Identifiers

PMID38058399
PMCPMC10696202
OpenAlexW4388920748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.